These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22265937)

  • 1. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary to: Goossens, G.A., Stas, M., Moons, P., 2012. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience. European Journal of Oncology Nursing 16 (5), 465-471.
    Hance SN; Glenn LL
    Eur J Oncol Nurs; 2012 Dec; 16(5):472. PubMed ID: 22884874
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of venous access devices by Advanced Practice Nursing teams: more research needed.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):473-4. PubMed ID: 23039923
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
    Kim JT; Oh TY; Chang WH; Jeong YK
    Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
    Di Carlo I; Pulvirenti E; Mannino M; Toro A
    Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience at a single institution with endovascular treatment of mechanical complications caused by implanted central venous access devices in pediatric and adult patients.
    Bessoud B; de Baere T; Kuoch V; Desruennes E; Cosset MF; Lassau N; Roche A
    AJR Am J Roentgenol; 2003 Feb; 180(2):527-32. PubMed ID: 12540466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
    Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
    Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
    Wilson GJ; van Noesel MM; Hop WC; van de Ven C
    J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of implantable chemotherapy reservoirs. Experience at the Hotel-Dieu of France].
    Antakly MC; Yazbeck P; Hayeck G; Yazigi A; Cherfane A
    J Med Liban; 1992; 40(2):108-11. PubMed ID: 1339879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
    Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
    Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Learning curve and early complications of totally implantable venous access devices: is tutoring the solution for the problem?].
    Di Carlo I; Toro A; Sofia M; Fasone MA; Barbagallo F; Russello D
    G Chir; 2004 Apr; 25(4):146-8. PubMed ID: 15283408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
    Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
    Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totally implantable central venous access ports. Analysis of 700 cases.
    Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
    J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of nursing in the prevention of complications of totally implantable venous access devices].
    Di Carlo I; Toro A; Fasone A; Barbagallo F; Di Stefano A; Cordio S; Russello D
    G Chir; 2003 Apr; 24(4):133-5. PubMed ID: 12886752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report.
    Di Carlo I; Fasone MA; Toro A; Castello G; Sparatore F; Cordio S
    G Chir; 2004; 25(11-12):417-9. PubMed ID: 15803820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
    Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
    Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.